Eyedetec Medical
Chronic Dry Eye Therapy Reimagined
Overview
Raised: $0
Total Commitments ($USD)
StartEngine
02/23/2024
04/29/2024
$497
Equity - Preferred
Series A
RegCF
$3.88
$15,198,193
2010
Healthcare & Pharmaceuticals
HealthTech
B2B2C
High
Low
Summary Profit and Loss Statement
| FY 2023 | FY 2022 | |
|---|---|---|
|
Revenue |
$411,720 |
$362,367 |
|
COGS |
$120,112 |
$180,311 |
|
Tax |
$0 |
$800 |
| ||
| ||
|
Net Income |
$-635,392 |
$-884,110 |
Summary Balance Sheet
| FY 2023 | FY 2022 | |
|---|---|---|
|
Cash |
$301,838 |
$407,228 |
|
Accounts Receivable |
$40,118 |
$17,385 |
|
Total Assets |
$451,362 |
$521,914 |
|
Short-Term Debt |
$1,041,720 |
$703,247 |
|
Long-Term Debt |
$5,475,542 |
$5,249,175 |
|
Total Liabilities |
$6,517,262 |
$5,952,422 |
Raise History
| Offering Name | Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| Eyedetec Medical | 04/29/2024 | StartEngine | $15,198,193 | $0 | Equity - Preferred | Not Funded | RegCF |
No prior online funding rounds.
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
